ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.02575
0.30%
Brent Oil
81.175
0.46%
Bitcoin
68,849.88
1.63%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Centogene NV (CNTG)

  7. Centogene NV (CNTG) Noticias

CNTG Centogene NV

0.371
0.00 (0.00%)
02 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Centogene NV CNTG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.371 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.371
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
31/5/202415:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202415:30GLOBECENTOGENE Announces Adoption of All Resolutions Tabled at..
29/5/202406:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/5/202406:20EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
15/5/202416:17GLOBECENTOGENE Reports Full Year 2023 Financial Results and..
15/5/202416:12EDGAR2Form 20-F - Annual and transition report of foreign private..
15/5/202416:10GLOBECENTOGENE Secures Approx. $20 Million to Strengthen Cash..
15/5/202416:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202415:56EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/5/202407:30GLOBECENTOGENE and Evotec Discover Promising New Molecule to..
14/5/202407:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/5/202405:30GLOBECENTOGENE Biodatabank Grows to Incorporate Disease Insights..
10/5/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/4/202415:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
19/3/202405:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
29/2/202416:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202416:00GLOBECENTOGENE Collaborates on Research Published in Science..
28/2/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202405:30GLOBECENTOGENE Announces Receipt of Nasdaq Notice of Delisting..
28/2/202405:30GLOBECENTOGENE Explores Strategic Alternatives
28/2/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/1/202405:30GLOBECENTOGENE and the Laboratory of Human Genetics of Infectious..
25/1/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202405:30GLOBECENTOGENE Receives French Research Tax Credit Accreditation
24/1/202405:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202405:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202405:30GLOBECENTOGENE and The Michael J. Fox Foundation Announce..
18/1/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/1/202405:30GLOBECENTOGENE Announces Preliminary Full Year 2023 Revenue
19/12/202306:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202305:30GLOBECENTOGENE Announces Voting Results of Extraordinary General..
18/12/202305:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202305:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/12/202305:30GLOBECENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study,..
01/12/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202305:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
28/11/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202307:30GLOBECENTOGENE, University College London, and Global Team of..
03/11/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202306:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202305:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202305:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
06/10/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202307:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
07/9/202316:00GLOBECENTOGENE Reports First Half 2023 Financial Results
07/9/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/9/202307:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
31/8/202315:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
31/8/202315:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
CNTG
Centogene NV
KUCN
CEURUSDT
Celo Euro
NYSE
SSD
Simpson Manufacturing
BIT
I08099
Intesa Sanpaolo
COIN
AGCETH
AdGroupCoin
BIT
I07185
INTESA SANPAOLO
BIT
I07249
INTESA SANPAOLO
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados